Page 927 - Adams and Stashak's Lameness in Horses, 7th Edition

Principles of Therapy for Lameness 893

18. Bohannon LK, Owens SD, Walker NJ, et al. The effects of thera- 42. Frisbie DD, Kawcak CE, Trotter GW, et al. Effects of triamci-
peutic concentrations of gentamicin, amikacin and hyaluronic nolone acetonide on an in vivo equine osteochondral fragment
acid on cultured bone marrow‐derived equine mesenchymal stem
VetBooks.ir 19. van Buul GM, Koevoet WLM, Kops N, et al. Platelet‐rich plasma 43. Frisbie DD, Kawcak CE, Baxter GM, et al. Effects of 6alpha‐meth-
exercise model. Equine Vet J 1997;29(5):349–359.
cells. Equine Vet J 2013;45(6):732–736.
ylprednisolone acetate on an equine osteochondral fragment exer-
cise model. Am J Vet Res 1998;59(12):1619–1628.
releasate inhibits inflammatory processes in osteoarthritic chon-
drocytes. Am J Sports Med 2011;39(11):2362–2370.
20. Caron JP. Intra‐articular injections for joint disease in horses. Vet 44. Frisbie D, Ghivizzani S, Robbins P, et al. Treatment of experimen-
tal equine osteoarthritis by in vivo delivery of the equine interleu-
Clin North Am Equine Pract 2005;21(3):559–573. kin‐1 receptor antagonist gene. Gene Ther 2002;9(1):12.
21. Caron J, Tardif G, Martel‐Pelletier J, et al. Modulation of matrix 45. Frisbie DD, Kawcak CE, Werpy NM, et al. Clinical, biochemical,
metalloprotease 13 (collagenase 3) gene expression in equine and histologic effects of intra‐articular administration of autolo-
chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res gous conditioned serum in horses with experimentally induced
1996;57:1631–1634. osteoarthritis. Am J Vet Res 2007;68:290–296.
22. Celeste C, Ionescu M, Robin P, et al. Repeated intraarticular injec- 46. Frisbie DD, Kawcak CE, Mcilwraith CW, et al. Evaluation of pol-
tions of triamcinolone acetonide alter cartilage matrix metabo- ysulfated glycosaminoglycan or sodium hyaluronan administered
lism measured by biomarkers in synovial fluid. J Orthop Res intra‐articularly for treatment of horses with experimentally
2005;23:602–610. induced osteoarthritis. Am J Vet Res 2009;70(2):203.
23. Chahla J, Dean CS, Moatshe G, et al. Concentrated bone marrow 47. Frisbie DD, Kawcak CE, Mcilwraith CW, et al. Intraarticu-
aspirate for the treatment of chondral injuries and osteoarthritis lar treatment of osteoarthritis with polyglycan assessed using
of the knee. Orthop J Sport Med 2016;4(1):2325967115625481. an equine experimental model. In Proceedings 36th Annual
24. Christensen L, Camitz L, Illigen KE, et al. Synovial incorporation Conference Veterinary Orthopedic Society, Steamboat Springs,
of polyacrylamide hydrogel after injection into normal and osteo- CO, 2009;6.
arthritic animal joints. Osteoarthritis Cartilage 2016;24(11): 48. Frisbie D, Kawcak C, Werpy N, et al. Combination of intraarticu-
1999–2002. lar (IA) triamcinolone acetonide and polysulfated glycosamino-
25. Chunekamrai S, Krook L, Lust G, et al. Changes in articular car- glycan compared to IA polysulfates glycosaminoglycan or placebo
tilage after intra‐articular injections of methylprednisolone ace- for treatment of osteoarthritis using an equine experimental
tate in horses. Am J Vet Res 1989;50:1733–1741. model. Proc Am Assoc Equine Pract 2010;56:25–26.
26. Dabareiner RM, Carter GK, Honnas CM. Injection of corticoster- 49. Gaustad G, Larsen S. Comparison of polysulphated glycosamino-
oids, hyaluronate, and amikacin into the navicular bursa in glycan and sodium hyaluronate with placebo in treatment of trau-
horses with signs of navicular area pain unresponsive to other matic arthritis in horses. Equine Vet J 1995;27(5):356–362.
treatments: 25 cases (1999–2002). J Am Vet Med Assoc 2003; 50. Genovese R. The use of corticosteroids in racetrack practice.
223(10):1469. Proceedings Symposium Effective Use of Corticosteroids in
27. Di Rosa M. Role in inflammation of glucocorticoid‐induced Veterinary Practice, 1983:56–65.
phospholipase inhibitory proteins. Prog Biochem Pharmacol 51. Gillespie CC, Adams SB, Moore GE. Methods and variables asso-
1985;20:55–62. ciated with the risk of septic arthritis following intra‐articular
28. Edmonds RE, Garvican ER, Smith RKW, et al. Influence of com- injections in horses: a survey of veterinarians. Vet Surg
monly used pharmaceutical agents on equine bone marrow‐derived 2016;45(8):1071–1076.
mesenchymal stem cell viability. Equine Vet J 2017;49(3):352–357. 52. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in
29. Farquhar T, Todhunter RJ, Fubini SL, et al. Effect of methylpred- the horse – a review. Vet J 2006;171(1):51–69.
nisolone and mechanical loading on canine articular cartilage in 53. Goodrich LR, Brower‐Toland BD, Warnick L, et al. Direct adeno-
explant culture. Osteoarthritis Cartilage 1996;4(1):55–62. virus‐mediated IGF‐I gene transduction of synovium induces per-
30. Ferris DJ, Frisbie DD, McIlwraith CW, et al. Current joint thera- sisting synovial fluid IGF‐I ligand elevations. Gene Ther
pies in equine practice: a survey of veterinarians, 2009. Equine Vet 2006;13(17):1253.
J 2011;43(5):530–535. 54. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of
31. Ferris DJ, Frisbie DD, Kisiday JD, et al. Clinical outcome after hyaluronic acid and its action mechanisms on experimental joint
intra‐articular administration of bone marrow derived mesenchy- pain in rats. Ann Rheum Dis 1993;52(11):817.
mal stem cells in 33 horses with stifle injury. Vet Surg 55. de Grauw JC, Visser‐Meijer MC, Lashley F, et al. Intra‐articular
2014;43:255–265. treatment with triamcinolone compared with triamcinolone with
32. Ferris DJ, Frisbie DD, Kisiday JD, et al. Clinical outcome after hyaluronate: a randomised open‐label multicentre clinical trial in
intra‐articular administration of bone marrow derived mesenchy- 80 lame horses. Equine Vet J 2016;48(2):152–158.
mal stem cells in 33 horses with stifle injury. Vet Surg 2014;43(3): 56. Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injec-
255–265. tion treatment in rheumatic disorders. Semin Arthritis Rheum
33. Filardo G, Kon E, Della Villa S, et al. Use of platelet‐rich plasma 1981;10(4):231.
for the treatment of refractory jumper’s knee. Int Orthop 57. Gustafson S, McIlwraith C, Jones R. Comparison of the effect of
2010;34(6):909–915. polysulfated glycosaminoglycan, corticosteroids and sodium hya-
34. Filardo G, Kon E, Buda R, et al. Platelet‐rich plasma intra‐articu- luronate in the potentiation of a subinfective dose of
lar knee injections for the treatment of degenerative cartilage Staphylococcus aureus in the midcarpal joint of horses. Am J Vet
lesions and osteoarthritis. Knee Surg Sport Traumatol Arthrosc Res 1989;50:2014–2017.
2011;19(4):528–535. 58. Gustafson S, McIlwraith C, Jones R, et al. Further investigations
35. Filardo G, Di Matteo B, Di Martino A, et al. Platelet‐rich plasma into the potentiation of infection by intra‐articular injection of
intra‐articular knee injections show no superiority versus visco- polysulfated glycosaminoglycan and the effect of filtration and
supplementation: a randomized controlled trial. Am J Sports Med intra‐articular injection of amikacin in horses. Am J Vet Res
2015;43(7):1575–1582. 1989;50:2018–2022.
36. Foland JW, Mcilwraith CW, Trotter GW, et al. Effect of betameth- 59. Hague BA, Honnas CM, Simpson RB, et al. Evaluation of skin
asone and exercise on equine carpal joints with osteochondral bacterial flora before and after aseptic preparation of clipped and
fragments. Vet Surg 1994;23(5):369–376. nonclipped arthrocentesis sites in horses. Vet Surg 1997;26(2):
37. Forrester JV, Wilkinson PC. Inhibition of leukocyte locomotion by 121–125.
hyaluronic acid. J Cell Sci 1981;48:315. 60. Higgins AJ, Lees P. The acute inflammatory process, arachidonic
38. Fortier LA, Potter HG, Rickey EJ, et al. Concentrated bone mar- acid metabolism and the mode of action of anti‐inflammatory
row aspirate improves full‐thickness cartilage repair compared drugs. Equine Vet J 1984;16(3):163–175.
with microfracture in the equine model. J Bone Joint Surg Am 61. Higuchi M, Masuda T, Susuda K, et al. Ultrastructure of the artic-
2010;92(10):1927–1937. ular cartilage after systemic administration of hydrocortisone in
39. Fortier L, Barker J, Strauss E, et al. The role of growth factors in the rabbit: an electron microscopic study. Clin Orthop 1980;
cartilage repair. Clin Orthop Relat Res 2011;469(10):2706–2715. 152:296–302.
40. Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet‐rich plasma. 62. Howard R, McIlwraith CW. Sodium hyaluronate in the treatment
Am J Sports Med 2009;37(11):2259–2272. of equine joint disease. Compend Contin Educ Pract Vet
41. Frean SP, Cambridge H, Lees P. Effects of anti‐arthritic drugs on 1993;15:473–481.
proteoglycan synthesis by equine cartilage. J Vet Pharmacol Ther 63. Howard R, McIlwraith CW. Hyaluronan and its use in the treat-
2002;25(4):289. ment of equine joint disease. In Mcilwraith CW, Trotter GW, eds.